HK1175786A1 - Synthetic lta mimetics and use thereof as vaccine component for therapy and/or prophylaxis against gram-positive infections lta / - Google Patents
Synthetic lta mimetics and use thereof as vaccine component for therapy and/or prophylaxis against gram-positive infections lta /Info
- Publication number
- HK1175786A1 HK1175786A1 HK13103062.2A HK13103062A HK1175786A1 HK 1175786 A1 HK1175786 A1 HK 1175786A1 HK 13103062 A HK13103062 A HK 13103062A HK 1175786 A1 HK1175786 A1 HK 1175786A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- lta
- mimetics
- therapy
- against gram
- synthetic
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 229940124856 vaccine component Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/11—Esters of phosphoric acids with hydroxyalkyl compounds without further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20110157947 EP2500349B1 (en) | 2011-03-11 | 2011-03-11 | Synthetic LTA mimetics and use thereof as vaccine component for therapy and/or prophylaxis against gram-positive infections |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1175786A1 true HK1175786A1 (en) | 2013-07-12 |
Family
ID=43828266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13103062.2A HK1175786A1 (en) | 2011-03-11 | 2013-03-12 | Synthetic lta mimetics and use thereof as vaccine component for therapy and/or prophylaxis against gram-positive infections lta / |
Country Status (7)
Country | Link |
---|---|
US (1) | US9290531B2 (xx) |
EP (1) | EP2500349B1 (xx) |
JP (1) | JP6154751B2 (xx) |
CA (1) | CA2829126A1 (xx) |
ES (1) | ES2544808T3 (xx) |
HK (1) | HK1175786A1 (xx) |
WO (1) | WO2012119846A1 (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2856085C (en) | 2011-11-18 | 2020-06-30 | National Research Council Of Canada | Clostridium difficile lipoteichoic acid and uses thereof |
EP3484908A4 (en) | 2016-07-15 | 2020-04-08 | AM Chemicals Llc | NON-NUCLEOSIDIC SOLID CARRIERS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTID SYNTHESIS |
KR101950881B1 (ko) * | 2017-08-10 | 2019-02-22 | 서울대학교산학협력단 | 리포테이코익산(Lipoteichoic acid(LTA))을 함유하는 피부 재생 및 창상 치유용 약학 조성물 |
CA3074703A1 (en) * | 2017-09-07 | 2019-03-14 | Merck Sharp & Dohme Corp. | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0807185T3 (da) * | 1995-01-30 | 2002-10-07 | Lunamed Ag | Antitumorpræparater indeholdende en lipoteichoinsyre fra streptococcus |
AUPQ137699A0 (en) | 1999-07-02 | 1999-07-22 | University Of New England, The | Control of acidosis |
JP2005526497A (ja) * | 2002-02-04 | 2005-09-08 | ビオミラ,インコーポレーテッド | 免疫刺激性、共有結合性脂質化オリゴヌクレオチド |
-
2011
- 2011-03-11 EP EP20110157947 patent/EP2500349B1/en not_active Not-in-force
- 2011-03-11 ES ES11157947.0T patent/ES2544808T3/es active Active
-
2012
- 2012-02-17 WO PCT/EP2012/052801 patent/WO2012119846A1/en active Application Filing
- 2012-02-17 US US14/002,459 patent/US9290531B2/en not_active Expired - Fee Related
- 2012-02-17 JP JP2013557032A patent/JP6154751B2/ja not_active Expired - Fee Related
- 2012-02-17 CA CA2829126A patent/CA2829126A1/en not_active Abandoned
-
2013
- 2013-03-12 HK HK13103062.2A patent/HK1175786A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2012119846A1 (en) | 2012-09-13 |
EP2500349B1 (en) | 2015-05-06 |
US9290531B2 (en) | 2016-03-22 |
CA2829126A1 (en) | 2012-09-13 |
JP2014507450A (ja) | 2014-03-27 |
ES2544808T3 (es) | 2015-09-04 |
JP6154751B2 (ja) | 2017-06-28 |
EP2500349A1 (en) | 2012-09-19 |
US20140050741A1 (en) | 2014-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1207002A1 (en) | Compositions comprising cocktails of antibacterial phages and uses thereof for the treatment of bacterial infections | |
HK1225649A1 (zh) | 用於治療細菌性感染的化合物和方法 | |
IL242770B (en) | A therapeutic combination that includes oxazolidinone-quinolones for use in the treatment of bacterial infections | |
HK1210018A1 (en) | Tailored liposomes for the treatment of bacterial infections | |
HK1218293A1 (zh) | 治療細菌感染的化合物和方法 | |
EP2869821A4 (en) | COMPOSITIONS AND METHODS FOR TREATING AND INHIBITING VIRAL INFECTIONS | |
GB201212588D0 (en) | Colicins for treating bacterial infections | |
EP2802353A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS | |
IL233486A0 (en) | Synthetic peptides for the treatment of bacterial infections | |
ZA201503474B (en) | Compositions and methods for treating bacterial infections | |
EP2969003A4 (en) | METHOD AND COMPOSITIONS FOR BACTERIAL INFECTIONS | |
EP2844258A4 (en) | METHOD AND COMPOSITIONS FOR TREATING BACTERIAL INFECTIONS | |
HK1175786A1 (en) | Synthetic lta mimetics and use thereof as vaccine component for therapy and/or prophylaxis against gram-positive infections lta / | |
EP2916653A4 (en) | ANTIBIOTIC METHODS AND ANTIBIOTIC COMPOSITIONS FOR BACTERIAL INFECTIONS | |
HK1212619A1 (zh) | 眼部感染的治療或預防方法 | |
IL234777A (en) | Erythuran or its salts suitable for pharmacological use in the treatment of Orthomix virus infections | |
ZA201308025B (en) | The use of secnidazole in treating dental infections | |
PL2838903T3 (pl) | Sposoby i kompozycje do leczenia zakażeń wirusowych | |
EP2854777A4 (en) | COMBINED THERAPY AND PROPHYLAXIS FOR GENITAL TRACT INFECTIONS | |
EP2665738A4 (en) | COMPOUNDS FOR TREATING BACTERIAL INFECTION | |
PL2771016T3 (pl) | Prymycyna i jej składniki do zastosowania w leczeniu lub zapobieganiu infekcjom powodowanym przez określone patogeny | |
EP2772248A4 (en) | PHARMACEUTICAL COMPOSITION AND KIT FOR THE TREATMENT OF BACTERIAL INFECTIONS | |
GB201223371D0 (en) | Novel mucinase for use in therapy or prophylaxis | |
GB201208770D0 (en) | Compounds for use in the treatment of adenovirus infections | |
GB201314623D0 (en) | Novel mucinase for use in therapy or prophylaxis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20220313 |